Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
416,598,522
-
Number of holders
-
131
-
Total 13F shares, excl. options
-
105,648,029
-
Shares change
-
-36,300,856
-
Total reported value, excl. options
-
$780,734,717
-
Value change
-
-$325,418,528
-
Put/Call ratio
-
64.47%
-
Number of buys
-
84
-
Number of sells
-
-54
-
Price
-
$7.39
Significant Holders of CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) as of Q3 2021
204 filings reported holding CLOV - CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock as of Q3 2021.
CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) has 131 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 105,648,029 shares
of 416,598,522 outstanding shares and own 25.36% of the company stock.
Largest 10 shareholders include GREENOAKS CAPITAL PARTNERS LLC (49,695,247 shares), VANGUARD GROUP INC (16,999,747 shares), PNC Financial Services Group, Inc. (6,611,767 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (6,098,045 shares), BAILLIE GIFFORD & CO (5,142,177 shares), BlackRock Inc. (3,486,214 shares), GEODE CAPITAL MANAGEMENT, LLC (1,789,062 shares), MORGAN STANLEY (1,666,193 shares), PERCEPTIVE ADVISORS LLC (1,500,000 shares), and STATE STREET CORP (1,268,209 shares).
This table shows the top 131 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.